Microgen LLC

La Marque, TX

UEI
C6KMJUPNY6R3
CAGE
3GAN6
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Business
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
903 Texas Ave, La Marque, TX 77568, USA
Founded
1999
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
We will study the effects of simulated microgravity and ionizing radiation on the complex process of virus reactivation… NNX14AD14G Shared Services Center $218,488
Pilot study of artificial gravity as a multi systems contermeasure to bed rest deconditioning NNJ06HC59G Johnson Space Center $34,449
Space flight induced reactivation of latent eipstein barr virus NNJ06HB73A Johnson Space Center $1,219,022
Pilot study of artificial gravity as a multi-syste m countermeasure to bed rest reconditioning NNJ04HD67G Johnson Space Center $120,183
Effects of simulated spaceflight on virus specific immunity NNJ04HD75G Johnson Space Center $802,609

Grant awards

Award Agency Obligated Awarded
PA21259, sbir, phase i, development of a high throughput assay for rapid detection of HSV and treponema pallidum R43PS005273 Office of Financial Resources (CDC) $299,801
Development of a high throughput assay for rapid screening of congenital cytomegalovirus infection using dried blood… R44DC019890 National Institute on Deafness and Other Communincation Disorders (NIH) $3,975,682
Development of a high throughput assay for rapid screening of congenital cytomegalovirus infection using dried blood… R43DC019890 National Institute on Deafness and Other Communincation Disorders (NIH) $583,226
The impact of maternal CMV infection on birth outcomes - congenital cytomegalovirus (CMV) infection is a leading… R03AI151426 National Institute of Allergy and Infectious Diseases (NIH) $447,575
Rapid user friendly POC diagnostic for HSV R43AI152629 National Institute of Allergy and Infectious Diseases (NIH) $189,631

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Prompt Diagnostics, Inc. UEI L28FVGJ715D7 Baltimore, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Lo Biosciences, Inc. UEI JPVWZEYKLXN3 North Bethesda, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Salus Discovery LLC UEI YJ6CYLKZ4JL9 Monona, WI 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Bioamp Diagnostics Inc. UEI DRVXMUC1N4X1 San Carlos, CA 325413 In-Vitro Diagnostic Substance Manufacturing
Gate Scientific, Inc. UEI YCWLED3EYTY5 Milpitas, CA 334516 Analytical Laboratory Instrument Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Microgen LLC is a woman-owned small disadvantaged business registered with the federal government to receive contract and grant awards. The company provides biotechnology products and services related to molecular diagnostics and life sciences research.

Microgen LLC has received multiple grant awards from agencies within the Department of Health and Human Services to develop rapid molecular diagnostic tests and conduct biomedical research. Several awards from the National Institutes of Health fund projects to create point-of-care tests for detecting congenital cytomegalovirus infection using dried blood spot samples, with the goal of enabling early detection and treatment of hearing loss in infants. Another NIH grant supports research on an intervention program to reduce biopsychosocial risks for pregnant Latina women and their infants. The company has also received funding from the Centers for Disease Control and Prevention for work on rapid assays to detect herpes simplex virus and syphilis. Additionally, the National Institute of Allergy and Infectious Diseases has provided grants to Microgen LLC for developing point-of-care tests to screen pregnant women's cytomegalovirus serostatus and creating a rapid diagnostic for herpes simplex virus. These awards demonstrate Microgen's expertise in molecular diagnostics, particularly for infectious diseases impacting maternal health and congenital disorders.

Quick answers

Is Microgen LLC registered in SAM.gov?

Yes. Microgen LLC's SAM.gov registration is active through May 10, 2027.

What is Microgen LLC's most recent federal award?

Microgen LLC's most recent federal grant award is PA21259, sbir, phase i, development of a high throughput assay for rapid detection of HSV and treponema pallidum (R43PS005273), from Office of Financial Resources (CDC), on September 30, 2023.

On GovTribe

See Microgen LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login